Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anisomycin does not activate p38MAPK in human platelets.

C Pampolina1, A McNicol

  • 1Department of Oral Biology, University of Manitoba, Winnipeg, Canada.

Thrombosis Research
|November 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Patients with Storage Pool Deficiency Using ATP Release and Dense Granule Counts.

Hematology (Amsterdam, Netherlands)·2016
Same author

Streptococcus sanguinis-induced cytokine release from platelets.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Further Studies on the Effects of the Intracellular Histamine Antagonist DPPE on Platelet Function.

Platelets·2010
Same author

Incorporation of map kinases into the platelet cytoskeleton.

Thrombosis research·2001
Same author

Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion.

Matrix biology : journal of the International Society for Matrix Biology·2001
Same author

Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.

Thrombosis and haemostasis·2001
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Anisomycin does not activate human platelets or their p38 mitogen-activated protein kinase (MAPK). This study shows anisomycin is ineffective for investigating p38MAPK roles in platelet function.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Hematology

Background:

  • Human platelets contain erk1, erk2, and p38 mitogen-activated protein kinase (MAPK).
  • The specific roles of MAPK cascades in platelet function are not fully understood.
  • MAPKs are implicated in cytoskeleton regulation and phospholipase A2 activation in platelets.

Purpose of the Study:

  • To investigate the role of p38MAPK in human platelet function.
  • To evaluate anisomycin as a p38MAPK activator and SB203580 as a p38MAPK inhibitor in platelets.

Main Methods:

  • Platelet aggregation assays were performed using various agonists (thrombin, collagen, U46619, A23187).
  • p38MAPK phosphorylation was assessed in intact platelets and platelet lysates.
  • Anisomycin and SB203580 were used to modulate p38MAPK activity.

Related Experiment Videos

Main Results:

  • Thrombin and collagen induced p38MAPK phosphorylation, which was blocked by SB203580.
  • Anisomycin did not induce platelet aggregation or potentiate responses to other agonists.
  • Anisomycin failed to induce or modulate p38MAPK phosphorylation in human platelets.
  • Anisomycin induced p38MAPK phosphorylation in rabbit lung and C3 fibroblasts.

Conclusions:

  • Anisomycin is ineffective for studying p38MAPK in human platelet function.
  • SB203580 effectively inhibits p38MAPK phosphorylation in platelets stimulated by thrombin and collagen.
  • Further research is needed to elucidate the precise functions of p38MAPK in platelets.